Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 7 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, AIDS-Related 2 Glioma 2 Burkitt Lymphoma 2 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Leukemia-Lymphoma, Adult T-Cell 1 Kidney Neoplasms 1 Intraocular Lymphoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Rituximab 17 Peripheral Blood Stem Cell Transplantation 15 Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 11 Cyclosporine 10 Mycophenolic Acid 9 Etoposide 9 Methotrexate 8 Filgrastim 8 Lenalidomide 7 Tacrolimus 6 Dexamethasone 6 Busulfan 6 Radiotherapy 5 Melphalan 5 Cytarabine 5 Carboplatin 5 Vorinostat 4 Thiotepa 4 Therapeutics 4 Psychiatric Rehabilitation 4 Bortezomib 4 Antilymphocyte Serum 4 Transplantation 3 Methylprednisolone 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Flow Cytometry 3 Dasatinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Intraocular Lymphoma × Lomustine × Lymphoid × Clear all

NCT00074191 2017-04-21

Protocol-A

OHSU Knight Cancer Institute

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡